Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: A population-based study

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 7, 2004, Pages 681-688

  Koppert, L B ^a   Janssen Heijnen, M L G ^b   Louwman, M W J ^b   Lemmens, V E P P ^b   Wijnhoven, B P L ^a   Tilanus, H W ^a   Coebergh, J W W ^a,b,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c IKZ   (Netherlands)

Author keywords

Comorbidity; Gastric cancer; Gastro oesophageal junction; Oesophageal cancer; Population based study

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DATA BASE; DIABETES MELLITUS; ESOPHAGUS CARCINOMA; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HYPERTENSION; LIVER DISEASE; MALE; NETHERLANDS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SQUAMOUS CELL CARCINOMA; STATISTICAL DISTRIBUTION; STOMACH CARCINOMA; ULCERATIVE COLITIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CARDIA; CARDIOVASCULAR DISEASES; COMORBIDITY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; REGRESSION ANALYSIS; STOMACH NEOPLASMS;

EID: 3142631922     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000108331.52416.f1     Document Type: Article

References (37)

1. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83:2049-2053.
2. Powell J, McConkey CC, Gillison EW, Spychal RT. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002; 102: 422-427.
3. Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 2002; 14:115-122.
4. Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995; 76:1116-1119.
5. Freedman J, Lagergren J, Bergstrom R, Naslund E, Nyren O. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia. Br J Surg 2000; 87:1087-1093.
6. Alberts SR, Cervantes A, Van De Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 2003; 14 (suppl 2):II31-II36.
7. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130:883-890.
8. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastro-esophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340:825-831.
9. Lagergren J, Bergstrom R, Lindgren A, Nyren O. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 2000; 85:340-346.
10. El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002; 50:368-372.
11. Tajima Y, Nakanishi Y, Yoshino T, Kokawa A, Kusano M, Shimoda T. Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus. Oncology 2001; 61:1-9.
12. Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg 1999; 86:529-535.
13. Heidl G, Langhans P, Mellin W, Bunte H, Grundmann E. Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma. J Cancer Res Clin Oncol 1993; 120:95-99.
14. Ruol A, Parenti A, Zaninotto G, Merigliano S, Costantini M, Cagol M, et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000; 88:2520-2528.
15. Ye W, Chow WH, Lagergren J, Yin L, Nyren O. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology 2001; 121:1286-1293.
16. Mendes de Almeida JC, Chaves P, Pereira AD, Altorki NK. Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study. Ann Surg 1997; 226:725-733, discussion 733-725.
17. Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993; 72:1155-1158.
18. Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4:85-92.
19. Zhang ZF, Kurtz RC, Sun M, Karpeh M Jr, Yu GP, Gargon N, et al. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996; 5:761-768.
20. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997; 89:1277-1284.
21. Brown LM, Hoover R, Silverman D, Baris D, Hayes R, Swanson GM, et al. Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 2001; 153:114-122.
22. Stein HJ, Brucher BL, Sendler A, Siewert JR. Esophageal cancer: patient evaluation and pre-treatment staging. Surg Oncol 2001; 10:103-111.
23. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333: 32-41.
24. Locke GR 3rd, Talley NJ, Carpenter HA, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology 1995; 109:1750-1756.
25. Coebergh JW, Janssen-Heijnen ML, Post PN, Razenberg PP. Serious comorbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996. J Clin Epidemiol 1999; 52:1131-1136.
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
27. Wittekind C, Henson DE, Hutter RVP, Sobin LH. TNM Supplement. A Commentary on Uniform Use, 2nd edn. New York: Wiley-Liss; 2001.
28. Vaughan TL, Kiemeney LA, McKnight B. Colorectal cancer in patients with esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4:93-97.
29. Lagergren J, Nyren O. No association between colon cancer and adenocarcinoma of the oesophagus in a population based cohort study in Sweden. Gut 1999; 44:819-821.
30. Lagergren J, Bergstrom R, Adami HO, Nyren O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 2000; 133:165-175.
31. Ye W, Chow WH, Lagergren J, Boffetta P, Boman G, Adami HO, Nyren O. Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma. Br J Cancer 2001; 85:1317-1321.
32. Harding SM. Gastroesophageal reflux, asthma, and mechanisms of interaction. Am J Med 2001; 111 (suppl 8A):8S-12S.
33. Canning BJ. Role of nerves in asthmatic inflammation and potential influence of gastroesophageal reflux disease. Am J Med 2001; 111 (suppl 8A):13S-17S.
34. Wayman J, Forman D, Griffin SM. Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry. Cancer Causes Control 2001; 12:943-949.
35. Bollschweiler E, Schroder W, Holscher AH, Siewert JR. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 2000; 87:1106-1110.
36. Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998; 90:150-155.
37. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999; 106:642-649.